Effects of testosterone on erythropoiesis in a female mouse model of anemia of inflammation

Endocrinology

Volumn 157, Issue 7, 2016, Pages 2937-2946

  Guo, Wen ^a   Schmidt, Paul J ^b   Fleming, Mark D ^b   Bhasin, Shalender ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; AMYLOID A1 PROTEIN; BONE MORPHOGENETIC PROTEIN 6; ERYTHROPOIETIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; SODIUM CHLORIDE; TESTOSTERONE; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ESTRADIOL;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRUCELLA ABORTUS; CHRONIC INFLAMMATION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; EXPERIMENTAL MODEL; FEMALE; HEMATOCRIT; LIVER; MALE; MEAN CORPUSCULAR VOLUME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; SPLEEN; SPLENOMEGALY; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; INFLAMMATION; METABOLISM;

ANEMIA; ANIMALS; ERYTHROPOIESIS; ERYTHROPOIETIN; ESTRADIOL; FEMALE; HEMOGLOBINS; INFLAMMATION; MICE; MICE, INBRED C57BL; TESTOSTERONE;

EID: 84977090495     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1150     Document Type: Article

References (57)

1. Schmidt PJ. Regulation of iron metabolism by hepcidin under conditions of inflammation. J Biol Chem. 2015;290:18975-18983
2. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am. 2014;28:671-681, vi
3. Weiss G, Goodnough LT. Anemia of chronic disease.NEngl J Med. 2005;352:1011-1023
4. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009;122:78-86
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463
6. Lopez-Contreras MJ, Zamora-Portero S, Lopez MA, Marin JF, Zamora S, Perez-Llamas F. Dietary intake and iron status of institutionalized elderly people: Relationship with different factors. J Nutr Health Aging. 2010;14:816-821
7. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011;24:313-326
8. Handelsman DJ, Liu PY. Androgen therapy in chronic renal failure. Baillieres Clin Endocrinol Metab. 1998;12:485-500
9. Adamu B, Ma'aji SM, Erwin PJ, Tleyjeh IM. Meta-analysis of randomized controlled trials on androgens versus erythropoietin for anaemia of chronic kidney disease: Implications for developing countries. Int J Nephrol. 2012;2012:580437
10. Carrero JJ, Bárány P, Yilmaz MI, et al. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesisstimulating agents in men with chronic kidney disease. Nephrol Dial Transplant. 2012;27:709-715
11. Stenvinkel P, Bárány P. Hypogonadism in males with chronic kidney disease: Another cause of resistance to erythropoiesis-stimulating agents? Contrib Nephrol. 2012;178:35-39
12. Waalen J, von Löhneysen K, Lee P, Xu X, Friedman JS. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol. 2011;87:107-116
13. Malgor LA, Valsecia M, Verges E, De Markowsky EE. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam. 1998; 48:99-105
14. Rivera S, Ganz T. Animal models of anemia of inflammation. Semin Hematol. 2009;46:351-357
15. Kim A, Fung E, Parikh SG, et al. A mouse model of anemia of inflammation: Complex pathogenesis with partial dependence on hepcidin. Blood. 2014;123:1129-1136
16. Gardenghi S, Renaud TM, Meloni A, et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood. 2014;123:1137-1145
17. Fraenkel PG. Critical models for the anemia of inflammation. Blood. 2014;123:1124-1125
18. Poli M, Asperti M, Naggi A, et al. Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. Blood. 2014;123:1564-1573
19. Poli M, Asperti M, Ruzzenenti P, et al. Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. Biochem Pharmacol. 2014;92:467-475
20. Poli M, Girelli D, Campostrini N, et al. Heparin: A potent inhibitor of hepcidin expression in vitro and in vivo. Blood. 2011;117:997-1004
21. Cooke KS, Hinkle B, Salimi-Moosavi H, et al. A fully human antihepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood. 2013;122:3054-3061
22. Sasu BJ, Cooke KS, Arvedson TL, et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood. 2010;115:3616-3624
23. Moriya J, He Q, Uenishi H, et al. Induction murine models of chronic fatigue syndrome by Brucella abortus antigen injections: Is anemia induced or not? Biomed Res Int. 2015;2015:191489
24. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659-661
25. Guo W, Bachman E, Li M, et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell. 2013;12:280-291
26. Guo W, Bachman E, Vogel J, et al. The effects of short-term and long-term testosterone supplementation on blood viscosity and erythrocyte deformability in healthy adult mice. Endocrinology. 2015;156:1623-1629
27. Beutler E. Red cell metabolism: A manual of biochemical methods. 3rd ed. New York: G and S, 1984;65-66
28. Guo W, Li M, Bhasin S. Testosterone supplementation improves anemia in aging male mice. J Gerontol A Biol Sci Med Sci. 2013; 69:505-513
29. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611-624
30. Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004;7:271-277
31. Torino AB, Gilberti Mde F, Costa E, Lima GA, Grotto HZ. Evaluation of red cell and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease. Rev Bras Hematol Hemoter. 2014;36:424-429
32. Bateman AP, McArdle F, Walsh TS. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med. 2009;37:1906-1912
33. Lorenz L, Arand J, Büchner K, et al. Reticulocyte haemoglobin content as a marker of iron deficiency. Arch Dis Child Fetal Neonatal Ed. 2015;100:F198-F202
34. Koulnis M, Pop R, Porpiglia E, Shearstone JR, Hidalgo D, Socolovsky M. Identification and analysis of mouse erythroid progenitors using the CD71/TER119 flow-cytometric assay. J Vis Exp. 2011;Pii 2809
35. Peslak SA, Wenger J, Bemis JC, et al. EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress. Blood. 2012;120:2501-2511
36. Wang Z, Vogel O, Kuhn G, Gassmann M, Vogel J. Decreased stability of erythroblastic islands in integrin beta3-deficient mice. Physiol Rep. 2013;1:e00018
37. Liu J, Zhang J, Ginzburg Y, et al. Quantitative analysis of murine terminal erythroid differentiation in vivo: Novel method to study normal and disordered erythropoiesis. Blood. 2013;121:e43-49
38. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276
39. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204-3209
40. Stromps JP, Fuchs P, Demir E, Grieb G, Reuber K, Pallua N. Intraalveolar TNF- in combined burn and inhalation injury compared with intraalveolar interleukin-6. J Burn Care Res. 2015;36: e55-e61
41. Deveci M, Eski M, Sengezer M, Kisa U. Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-alpha levels in burned rats. Burns. 2000;26:41-45
42. Ishikawa N, Kobayashi Y, Fujii Y, Kobayashi M. Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric epilepsy patients with frequent, refractory generalized motor seizures. Seizure. 2015;25:136-140
43. Xi Q, Liu Z, Liu W, Zhao Z, Luo Q, Huang Z. Chronic thromboembolic pulmonary hypertension is not associated with iron overload. Cardiovasc Pathol. 2015;24:76-79
44. Shanmugam NK, Ellenbogen S, Trebicka E, et al. Tumor necrosis factor alpha inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis. PLoS One. 2012;7:e38136
45. Salama MF, Bayele HK, Srai SS. Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter. J Biomed Sci. 2012;19:83
46. Parrow NL, Fleming RE. Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr. 2014;34:77-94
47. Rausa M, Ghitti M, Pagani A, et al. Identification of TMPRSS6 cleavage sites of hemojuvelin. J Cell Mol Med. 2015;19:879-888
48. Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol. 2010;2010:750643
49. Douglas SW, Adamson JW. The anemia of chronic disorders: Studies of marrow regulation and iron metabolism. Blood. 1975;45:55-65
50. Prince OD, Langdon JM, Layman AJ, et al. Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica. 2012;97:1648-1656
51. Schwoebel F, van Eijk LT, Zboralski D, et al. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood. 2013;121:2311-2315
52. Chikazawa S, Nakazawa T, Hori Y, et al. Change in serum ferritin concentration in experimentally induced anemia of chronic inflammation in dogs. J Vet Med Sci. 2013;75:1419-1426
53. Kautz L, Jung G, Du X, et al. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of -thalassemia. Blood. 2015;126:2031-2037
54. van Santen S, Dongen-Lases EC, Vegt F, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011; 63:3672-3680
55. Ramos E, Kautz L, Rodriguez R, et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology. 2011;53:1333-1341
56. Beggs LA, Yarrow JF, Conover CF, et al. Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone.AmJ Physiol Endocrinol Metab. 2014;307: E456-E461
57. Rochira V, Zirilli L, Madeo B, Maffei L, Carani C. Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men. J Steroid Biochem Mol Biol. 2009;113: 189-194